SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Blame for Obesity Common Among Patients, Clinicians Globally

Obesity, a chronic disease, is still treated as a personal failing.

Colon Cleanses Pose Risks With No Proven Benefit

Colon cleansing claims are unsupported by evidence, while adverse effects, including hyponatremia, hypokalemia, and nephropathy, are well documented.

Can AI Improve Glaucoma Screening in Primary Care Settings?

AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency and detection.

Menopause: When to Treat and When to Wait

Early menopause demands tailored care: Premature estrogen loss increases bone loss and cardiovascular risk, so management should differ from typical cases.

US Senators Reach Deal on Capping Insulin Costs At $35 Per Month, Semafor Reports

A bipartisan group of ⁠U.S. senators has reached a ⁠deal on capping the ⁠price of ‌a month's supply of insulin at $35, Semafor reported on Wednesday, citing ‌an interview...

Body Map Reveals Widespread Pain in Chronic Pancreatitis

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and abdominal pain and is linked to more severe pain.

Todays Updates

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising recurrence risk.

Todays Updates

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Ten-year findings suggest some patients may safely receive less treatment, potentially lowering side effects without raising recurrence risk.

Latest News

Obesity, a chronic disease, is still treated as a personal failing.

Colon cleansing claims are unsupported by evidence, while adverse effects, including hyponatremia, hypokalemia, and nephropathy, are well documented.

AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency and detection.

Early menopause demands tailored care: Premature estrogen loss increases bone loss and cardiovascular risk, so management should differ from typical cases.

A bipartisan group of ⁠U.S. senators has reached a ⁠deal on capping the ⁠price of ‌a month's supply of insulin at $35, Semafor reported on Wednesday, citing ‌an interview...

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and abdominal pain and is linked to more severe pain.

News All Time

Brazilian 10-Year Diabetes Risk Calculator

A Brazilian calculator using up to 12 clinical and laboratory predictors estimates an individual’s 10 year diabetes risk and may better prioritize patients for prevention than FINDRISC.

Eye Condition Risk Elevated With Semaglutide, but Still Low

New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

Judge Says he Will Bar RFK Move Aimed At Cutting Gender-affirming Care for Minors

A U.S. judge on Thursday said he would block an effort by Health Secretary Robert F. Kennedy Jr that would have sharply restricted medical providers from ⁠providing gender...

Axitinib Ups Neuroendocrine Tumor Objective Response Rate

Patients were randomly assigned 1:1 to receive either axitinib 5 mg orally twice daily or matching placebo, both combined with octreotide long-acting release 30 mg, in an international study.

New Model May Improve Surgical Risk Prediction in Cirrhosis

A new European risk model may improve the prediction of postoperative mortality in patients with cirrhosis.

Frequent Insulin Infusion Site Failures ‘a Huge Problem’

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

GLP-1s Tied to Lower Risk of Psychiatric Decline

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A1c or CGM Metrics: Which Should Be the Gold Standard?

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Four-Drug Regimen Superior to Escalating Metformin in T2D

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

Keto Diet Boosts Aerobic Fitness in Hyperglycemic Mice

In hyperglycemic male mice, a ketogenic diet normalizes blood glucose and restores response to aerobic training.

Female Survival Advantage Narrows in Midlife Due to Cancer

A new cohort study finds that female reproductive cancers are a major cause of deaths in women aged 35-60 years, and eliminating these cancers would widen the known survival gap between sexes.

FDA Okays Higher-Dose Wegovy Injection for Weight Loss

The approval is part of a new FDA pilot program.

Australian Private Health Insurers Are Buying Up GP Clinics

Vertical integration is likely to reduce patient choice, restrict doctors’ referrals and prescriptions, and increase costs in the long term, critics say.

GLP-1s Linked to Lower Mortality in Patients With Brain Mets

Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, new data suggest.

Osteoarthritis Knee Pain Impairs Diabetes Glycemic Control

New research hints at a connection between knee pain and glycemic results, but more research is needed.

Inpatient Glucose Testing Triples Postpartum Screening

Giving an inpatient oral glucose tolerance test before delivery discharge for women with gestational diabetes tripled the completion rate compared to postpartum testing.